Last update 03 Jan 2025

64Cu-LLP2A(Washington University School of Medicine)

Overview

Basic Info

Drug Type
Chemical drugs, Diagnostic radiopharmaceuticals
Synonyms-
Target-
Action-
Mechanism
PET imaging(Positron-emission tomography enhancers)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Multiple Myeloma
Originator Organization
Washington University School of MedicineWashington University School of Medicine
Active Organization-
Inactive Organization
Washington University School of MedicineWashington University School of Medicine
License Organization-
Drug Highest PhaseDiscontinuedEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with 64Cu-LLP2A(Washington University School of Medicine)
NCT03804424
/ TerminatedEarly Phase 1IIT
Early Phase I Evaluation of 64Cu-LLP2A for Imaging Multiple Myeloma
100 Clinical Results associated with 64Cu-LLP2A(Washington University School of Medicine)
Login to view more data
100 Translational Medicine associated with 64Cu-LLP2A(Washington University School of Medicine)
Login to view more data
100 Patents (Medical) associated with 64Cu-LLP2A(Washington University School of Medicine)
Login to view more data
100 Deals associated with 64Cu-LLP2A(Washington University School of Medicine)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaPhase 1
United States
Washington University School of MedicineWashington University School of Medicine
20 Nov 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free